Segment Information (Tables)

3 Months Ended

Mar. 31, 2024

Segment Reporting [Abstract]

Financial Information by Segment

The following tables present financial information by segment:

	Three Months Ended
	March 31,
	2024		2023
Net revenue:
Products & Healthcare Services	$	1,974,837	$	1,915,489
Patient Direct		637,843		607,360
Consolidated net revenue	$	2,612,680	$	2,522,849
Operating income:
Products & Healthcare Services	$	11,486	$	1,820
Patient Direct		45,879		45,849
Acquisition-related charges and intangible amortization		(20,313)		(22,188)
Exit and realignment charges, net		(27,356)		(15,674)
Consolidated operating income	$	9,696	$	9,807
Depreciation and amortization:
Products & Healthcare Services	$	23,366	$	18,566
Patient Direct		50,729		52,360
Consolidated depreciation and amortization	$	74,095	$	70,926
Share-based compensation:
Products & Healthcare Services	$	4,769	$	4,498
Patient Direct		1,407		1,852
Other(1)		690		113
Consolidated share-based compensation	$	6,866	$	6,463
Capital expenditures:
Products & Healthcare Services	$	8,250	$	6,332
Patient Direct		41,158		45,158
Consolidated capital expenditures	$	49,408	$	51,490

(1) Other share-based compensation expense is captured within exit and realignment charges, net or acquisition-related charges for the three months ended March 31, 2024 and 2023.

Consolidated Total Assets

	March 31, 2024		December 31, 2023
Total assets:
Products & Healthcare Services	$	2,456,341	$	2,359,825
Patient Direct		2,506,786		2,490,460
Segment assets		4,963,127		4,850,285
Cash and cash equivalents		244,866		243,037
Consolidated total assets	$	5,207,993	$	5,093,322

Financial Information by Geographic Area

The following table presents net revenue by geographic area, which were attributed based on the location from which we ship products or provide services:

	Three Months Ended
	March 31,
	2024		2023
Net revenue:
United States	$	2,550,610	$	2,452,936
International		62,070		69,913
Consolidated net revenue	$	2,612,680	$	2,522,849